Showing 51 - 60 of 60
Persistent link: https://www.econbiz.de/10007764361
Persistent link: https://www.econbiz.de/10009967984
Persistent link: https://www.econbiz.de/10008077597
Persistent link: https://www.econbiz.de/10008077598
Persistent link: https://www.econbiz.de/10009264896
Persistent link: https://www.econbiz.de/10009804616
Although pharmaceutical counterfeiting incidents can be traced back thousands of years, it has been downplayed and even dismissed by pharmaceutical manufacturers in the past. That has changed. Pharmaceutical firms are newly dedicated to eradicate counterfeits globally and spending more money on...
Persistent link: https://www.econbiz.de/10005443224
Persistent link: https://www.econbiz.de/10005412117
The debate over access to medicines has principally centered on pharmaceutical patents and prohibitively high drug prices. Although a less recognized problem, counterfeit pharmaceuticals are certainly a more insidious barrier to access. Pharmaceutical counterfeiting is an invisible threat, not...
Persistent link: https://www.econbiz.de/10005694750
Persistent link: https://www.econbiz.de/10011033925